The Artificial Blood Pump Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.8 billion by 2034, registering a CAGR of 9.5%. This growth trajectory is underpinned by several key factors, including an increasing prevalence of cardiovascular diseases, advancements in medical technology, and a growing aging population that requires enhanced healthcare solutions. The demand...